BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2021 6:46:56 AM | Browse: 718 | Download: 1929
 |
Received |
|
2021-01-06 13:44 |
|
Peer-Review Started |
|
2021-01-06 13:45 |
|
First Decision by Editorial Office Director |
|
2021-05-05 22:18 |
|
Return for Revision |
|
2021-05-05 22:18 |
|
Revised |
|
2021-05-15 09:29 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-07-29 02:54 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-07-29 08:06 |
|
Articles in Press |
|
2021-07-29 08:06 |
|
Edit the Manuscript by Language Editor |
|
2021-08-17 21:14 |
|
Typeset the Manuscript |
|
2021-09-02 03:46 |
|
Publish the Manuscript Online |
|
2021-09-09 06:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yin-Lian Wu, Rahul Kumar, Ming-Fang Wang, Medha Singh, Jiao-Feng Huang, Yue-Yong Zhu and Su Lin |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chinese National 13th Five-Year Plan's Science and Technology Projects |
2017ZX10202201 |
|
| Corresponding Author |
Su Lin, MD, PhD, Associate Chief Physician, Professor, Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou 350005, Fujian Province, China. sumer5129@fjmu.edu.cn |
| Key Words |
Metabolic associated fatty liver disease; Non-invasive fibrosis scores; Fibrosis-4 index; Non-alcoholic fatty liver disease fibrosis score; Aspartate aminotransferase to platelet ratio index; BARD |
| Core Tip |
Metabolic associated fatty liver disease (MAFLD) is a new concept proposed in 2020 to re-define fatty liver disease. The utility of non-invasive fibrosis scores as well as their optimal thresholds for MAFLD remains unknown. We validated the conventional non-invasive scores including aspartate aminotransferase to platelet ratio index, fibrosis-4 index, diabetes score (BARD), and non-alcoholic fatty liver disease fibrosis score in patients with MAFLD. The results indicate that the conventional scores may lead to a high rate of misdiagnosis in MAFLD. Novel scoring system for fibrosis is urgently needed. |
| Publish Date |
2021-09-09 06:46 |
| Citation |
Wu YL, Kumar R, Wang MF, Singh M, Huang JF, Zhu YY, Lin S. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. World J Gastroenterol 2021; 27(34): 5753-5763 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i34/5753.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i34.5753 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
